LCD L39678: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — Noridian
Policy LCD-L39678 · Pulmonology
New MolDX guidelines will impact pulmonary nodule billing practices.
Code intelligence
Z12.2 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Z12.2.
Elevated code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Elevated
0
Critical
0%
1
High
33%
2
Routine
67%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L37897: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer — Noridian
Policy LCD-L37897 · Oncology
New liquid biopsy tests for lung cancer impact billing.
LCD L37899: MolDX: Inivata™, InvisionFirst®, Liquid Biopsy for Patients with Lung Cancer — Noridian
Policy LCD-L37899 · Oncology
New liquid biopsy tests for lung cancer impact billing.
Audit documentation
Building an audit file that includes Z12.2?
The Tripwire Audit Pack exports 12 months of Pulmonology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Pulmonology audit pack — $349One-time purchase · not a subscription